(i) Describe the aetiopathogenesis of carcinoma colon.
(ii) Briefly mention the management of carcinoma of descending colon in a 65-year-old male who has presented with intestinal obstruction.
15 marks · directive: Describe and mention
The core of a good answer
Colon cancer arises mostly through the adenoma-carcinoma sequence driven by APC loss with Wnt/β-catenin activation, KRAS and PI3K activation and TP53 loss, with mismatch-repair deficiency (including Lynch syndrome) as an alternative pathway, on a background of age, red and processed meat, obesity, inactivity, smoking, alcohol, inflammatory bowel disease and hereditary syndromes; an obstructing descending colon cancer in a 65-year-old needs resuscitation and CT, then emergency resection (Hartmann's procedure is the most common operation for malignant obstruction of the distal colon) or a self-expanding metal stent as a bridge to surgery or as palliation, followed by chemotherapy by stage.
An outline written by upsc.help, not an official UPSC answer; every fact checked by a separate review. How we work
What the question asks
Part (i) (7 marks) needs risk factors and molecular pathways in a structured way. Part (ii) (8 marks) needs emergency assessment and the choice of operation for a left-sided malignant obstruction, then oncological follow-through.
Answer outline
Introduction
Large bowel obstruction is most often due to tumours or volvulus, and an obstructing colon cancer needs both emergency care and cancer treatment.
Risk factors
- Older age; red and processed meat; obesity, lack of physical exercise, smoking, alcohol above one drink a day.
- Inflammatory bowel disease.
- Family history (two or more affected first-degree relatives give two to three times the risk); hereditary syndromes: familial adenomatous polyposis (APC), Lynch syndrome (about 3% of colorectal cancers), serrated polyposis.
- Protective: whole grains and probably fibre, calcium, adequate vitamin D, physical activity, aspirin in people at high risk.
Pathogenesis
- Adenoma-carcinoma sequence: APC, the most commonly mutated gene, is lost, so β-catenin accumulates and Wnt signalling is activated; oncogenes such as KRAS, RAF and PI3K and loss of TGF-β signalling and TP53 drive progression to carcinoma.
- Mismatch repair deficiency in 15 to 18% of tumours, about 3% from Lynch syndrome.
- Promoters: deoxycholic acid rises with high-fat diets; Streptococcus gallolyticus and colibactin-producing E. coli are linked to colorectal cancer.
(ii) Initial management of obstruction
- Look for a closed-loop obstruction or perforation, which are surgical emergencies; give IV fluids, correct dehydration and electrolytes, and decompress with a nasogastric tube.
- CT, which is more accurate than plain X-rays, to confirm the obstruction and stage the cancer.
(ii) Definitive options
- Emergency resection: Hartmann's procedure (resection with closure of the distal stump and an end colostomy) is the most common operation for malignant obstruction of the distal colon, and is used when perforation and peritonitis or injured proximal bowel make anastomosis unsafe.
- Self-expanding metal stent placed endoscopically as a bridge to surgery, or as palliation.
- Oncological follow-through: chemotherapy (fluorouracil or capecitabine with oxaliplatin, as CAPOX or FOLFOX) is integral for stage III disease; follow-up with CEA, CT for the first 3 years and colonoscopy after 1 year.
Conclusion
Understanding the molecular pathways explains screening and hereditary risk; in obstruction, resuscitation, staging and a tailored operation (resection or stent as a bridge) balance cure against operative risk.
Facts to remember
- Most colorectal cancers involve APC loss with β-catenin accumulation; KRAS, PI3K and TP53 mutations drive progression.
- Mismatch repair deficiency is found in 15 to 18% of colorectal tumours; Lynch syndrome is present in about 3% of people with colorectal cancer.
- Two or more affected first-degree relatives confer a 2 to 3-fold risk.
- Hartmann's procedure (rectosigmoid resection, closed anorectal stump, end colostomy) is the most common operation for malignant obstruction of the distal colon.
- Self-expanding metal stents can be used as a bridge to surgery or as palliation in malignant large bowel obstruction; chemotherapy with fluorouracil or capecitabine and oxaliplatin is integral for stage III colon cancer.